The Valley Desk

ArticleACR open rheumatologyPublished

Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
ACR open rheumatology
Published
PubMed ID
36604812
PubMed Central ID
PMC9926068
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal